POM Pomdoctor Limited

1.610USD0.00%Mkt Cap: 57.91M USDP/E: —

Pomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. The company develops an online medical services platform for chronic diseases in China. The company focuses on chr…

Institutional holders6 on file

Key Statistics

Company
Market Cap57.91M USD
Enterprise Value405.54M USD
Revenue (TTM)61.57M USD
Gross Profit7.84M USD
Net Income (TTM)-31.89M USD
Revenue/Share33.98 USD
Last Price1.610 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees165
CountryUS
SectorHealthcare
IndustryPharmaceutical Retailers
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-1.20
EV/Revenue6.59
P/S0.14
P/B-0.05
EPS (TTM)-6.05 USD
EPS (Forward)—
52W Range
0.43301% of range102.42
52W High102.42 USD
52W Low0.4330 USD
Profitability
Gross Margin13.07%
Oper. Margin-82.35%
EBITDA Margin-82.30%
Profit Margin-53.16%
ROE46.83%
ROA-197.64%
ROIC—
ROCE—
Growth
Revenue Growth6.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-22.27M USD
CapEx (TTM)151.16K USD
FCF Margin1.00%
FCF Yield1.06%
Net Debt65.63M USD
Net Debt/EBITDA-1.30
Net Debt/FCF106.66
Balance Sheet
Debt/Equity-1.00
Current Ratio0.35
Quick Ratio0.28
Book Value/Sh-4.56 USD
Cash/Share0.82 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:18
Split DateJun 22, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.35.76M
Float1.12M
Insiders0.00%
Institutions0.01%
Short Interest
Short Ratio0.0d
Short % Float13.09%
Short % Out.9.01%
Shares Short250.45K
Technical
SMA 501.166 (+38.1%)
SMA 2002.715 (-40.7%)
Beta—
S&P 52W Chg12.00%
Avg Vol (30d)3.54M
Avg Vol (10d)398.47K
Technical Indicators
RSI (14)53.1
MACD0.1199
MACD Signal0.1481
MACD Hist.-0.0281
BB Upper1.997 USD
BB Middle1.582 USD
BB Lower1.167 USD
BB Width52.45%
ATR (14)0.3252 USD
Vol Ratio (20d)0.01x

About Pomdoctor (NASDAQ: POM)

›

Pomdoctor (NASDAQ: POM) is listed on Nasdaq, where its shares trade in USD. It belongs to the Pharmaceutical Retailers industry, part of the Healthcare sector, and reports about 165 employees.

The shares were at 1.610 USD on 19 November 2026, down 97.9% over 52 weeks. Its 52-week range is 0.4330 USD to 102.42 USD: the price is 98.4% below the high and 271.8% above the low.

Its market capitalisation is 57.91M USD.

Pomdoctor reports return on equity of 46.8%, an operating margin of -82.3% and revenue up 6.0% year over year.

Its debt exceeds its cash by 437.52M CNY. Its Piotroski F-score is 4 out of 9, an average reading of its financial health.